Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IRMET (Istituto di Ricerche Mediche Elettronucleari) is a premier diagnostic imaging and nuclear medicine center located in Turin, Italy. As a center of excellence, it specializes in Positron Emission Tomography (PET/CT) and other advanced molecular imaging techniques used primarily for oncology, neurology, and cardiology diagnostics. The company plays a significant role in clinical research, collaborating with pharmaceutical companies and academic institutions to evaluate new tracers and diagnostic protocols. Since 2014, IRMET has operated as a key subsidiary of Affidea, the leading European provider of diagnostic imaging and cancer care services. The facility is equipped with an on-site cyclotron, enabling the production of radiopharmaceuticals for both clinical use and research applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IRMET.